Kevin James Craig's Insider Trades & SAST Disclosures

Kevin James Craig's most recent trade in ATAI Life Sciences N.V. was a trade of 11,563 Common Shares done at an average price of $1.3 . Disclosure was reported to the exchange on March 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
ATAI Life Sciences N.V.
Kevin James Craig Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.35 per share. 21 Mar 2025 11,563 8,437 - 1.3 15,610 Common Shares
ATAI Life Sciences N.V.
Kevin James Craig Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 20,000 0 - - Restricted Stock Units
ATAI Life Sciences N.V.
Kevin James Craig Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 20,000 20,000 - - Common Shares
ATAI Life Sciences N.V.
Kevin James Craig Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 757,915 757,915 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades